Results 31 to 40 of about 27,340 (76)

Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study. [PDF]

J Clin Oncol, 2019
Carmona-Bayonas A, Jiménez-Fonseca P, Lamarca Á, Barriuso J, Castaño Á, Benavent M, Alonso V, Riesco-Martínez MDC, Alonso-Gordoa T, Custodio A, Sánchez Cánovas M, Hernando Cubero J, López C, Lacasta A, Fernández Montes A, Marazuela M, Crespo G, Escudero P, Diaz JÁ, Feliciangeli E, Gallego J, Llanos M, Segura Á, Vilardell F, Percovich JC, Grande E, Capdevila J, Valle JW, García-Carbonero R.   +28 more
europepmc   +1 more source

Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer. [PDF]

BMC Cancer, 2019
Sarasqueta C, Perales A, Escobar A, Baré M, Redondo M, Fernández de Larrea N, Briones E, Piera JM, Zunzunegui MV, Quintana JM, REDISECC-CARESS/CCR group.   +10 more
europepmc   +1 more source

Strengthening Fungal Infection Diagnosis and Treatment: An In-depth Analysis of Capabilities in Honduras. [PDF]

Open Forum Infect Dis
Ortiz B, Varela D, Fontecha G, Torres K, Cornely OA, Salmanton-García J.   +5 more
europepmc   +1 more source

Impact of errors of creatinine and cystatin C equations in the selection of living kidney donors. [PDF]

Clin Kidney J, 2019
González-Rinne A, Luis-Lima S, Escamilla B, Negrín-Mena N, Ramírez A, Morales A, Vega N, García P, Cabello E, Marrero-Miranda D, Aldea-Perona A, Alvarez A, Abad MDC, Pérez-Tamajón L, González-Rinne F, González-Delgado A, Díaz Martín L, Jiménez-Sosa A, Torres A, Porrini E.   +19 more
europepmc   +1 more source

What is history? Reflections from the edge of empires, nation-states, and disciplines. [PDF]

Dialect Anthropol, 2021
Hylton F.
europepmc   +1 more source

Colorectal cancer health services research study protocol: the CCR-CARESS observational prospective cohort project. [PDF]

BMC Cancer, 2016
Quintana JM, Gonzalez N, Anton-Ladislao A, Redondo M, Bare M, Fernandez de Larrea N, Briones E, Escobar A, Sarasqueta C, Garcia-Gutierrez S, Aguirre U, REDISSEC-CARESS/CCR group.   +11 more
europepmc   +1 more source

Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study. [PDF]

BMC Cancer, 2018
Fernández A, Salgado M, García A, Buxò E, Vera R, Adeva J, Jiménez-Fonseca P, Quintero G, Llorca C, Cañabate M, López LJ, Muñoz A, Ramírez P, González P, López C, Reboredo M, Gallardo E, Sanchez-Cánovas M, Gallego J, Guillén C, Ruiz-Miravet N, Navarro-Pérez V, De la Cámara J, Alés-Díaz I, Pazo-Cid RA, Carmona-Bayonas A.   +25 more
europepmc   +1 more source

Factors Associated with Prolonged Patient-Attributable Delay in the Diagnosis of Colorectal Cancer. [PDF]

Cancer Res Treat, 2018
Zarcos-Pedrinaci I, Téllez T, Rivas-Ruiz F, Padilla-Ruiz MDC, Alcaide J, Rueda A, Baré ML, Suárez-Varela MMM, Briones E, Sarasqueta C, Fernández-Larrea N, Escobar A, Quintana JM, Redondo M.   +13 more
europepmc   +1 more source

Factors that influence treatment delay in patients with colorectal cancer. [PDF]

Oncotarget, 2017
Zarcos-Pedrinaci I, Fernández-López A, Téllez T, Rivas-Ruiz F, Rueda A, Morales Suarez-Varela MM, Briones E, Baré M, Escobar A, Sarasqueta C, de Larrea NF, Aguirre U, Quintana JM, Redondo M, CARESS-CCR Study Group.   +14 more
europepmc   +1 more source